Related references
Note: Only part of the references are listed.Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19
Rajesh K. Thimmulappa et al.
HELIYON (2021)
Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection
Anchalee Prasansuklab et al.
JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE (2021)
Coronavirus biology and replication: implications for SARS-CoV-2
Philip V'kovski et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Haibo Zhang et al.
INTENSIVE CARE MEDICINE (2020)
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
Xin Liu et al.
JOURNAL OF GENETICS AND GENOMICS (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Potential effects of curcumin in the treatment ofCOVID-19 infection
Fatemeh Zahedipour et al.
PHYTOTHERAPY RESEARCH (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping
Maria Romano et al.
CELLS (2020)
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Yadi Zhou et al.
CELL DISCOVERY (2020)
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Yuan Huang et al.
ACTA PHARMACOLOGICA SINICA (2020)
The Potential of Silver Nanoparticles for Antiviral and Antibacterial Applications: A Mechanism of Action
Atiqah Salleh et al.
NANOMATERIALS (2020)
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review
W. Joost Wiersinga et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial
Mehdi Hassaniazad et al.
TRIALS (2020)
Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?
Sangiliyandi Gurunathan et al.
NANOMATERIALS (2020)
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients
Hamed Valizadeh et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors
Mahmoud A. A. Ibrahim et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2020)
Nanoparticle-Based Strategies to Combat COVID-19
Riddhiman Medhi et al.
ACS APPLIED NANO MATERIALS (2020)
The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?
Andrea D. Fuzimoto et al.
JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE (2020)
Enhancing Curcumin Oral Bioavailability Through Nanoformulations
Vinod S. Ipar et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2019)
Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
Kyeong-Ok Chang et al.
VIRUSES-BASEL (2019)
Anti-infective Properties of the Golden Spice Curcumin
Dimas Praditya et al.
FRONTIERS IN MICROBIOLOGY (2019)
Curcumin: Recent Advances in the Development of Strategies to Improve Oral Bioavailability
Katherine Z. Sanidad et al.
ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 10 (2019)
Evaluation of the Efficiency of Interparticle Interactions in Nanosystems
Hanna O. Demchenko et al.
JOURNAL OF NANOTECHNOLOGY (2019)
Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections
David Lembo et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism
Valeria Cagno et al.
NATURE MATERIALS (2018)
Enhanced nanoparticle uptake into virus infected cells: Could nanoparticles be useful in antiviral therapy?
Yasmin Abo-zeid et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies
Patricia C. Pires et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Nanoparticles in Medicine: A Focus on Vascular Oxidative Stress
M. D. Mauricio et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Micelles Structure Development as a Strategy to Improve Smart Cancer Therapy
Nemany A. N. Hanafy et al.
CANCERS (2018)
Multisite Inhibitors for Enteric Coronavirus: Antiviral Cationic Carbon Dots Based on Curcumin
Du Ting et al.
ACS APPLIED NANO MATERIALS (2018)
Curcumin, an active component of turmeric (Curcuma longa), and its effects on health
Betul Kocaadam et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2017)
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies
Alessandro Allegra et al.
CANCER INVESTIGATION (2017)
Microemulsion utility in pharmaceuticals: Implications for multi-drug delivery
Shannon P. Callender et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Development of antibody-modified chitosan nanoparticles for the targeted delivery of si A across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes
Jijin Gu et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2017)
Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding
Bryan C. Mounce et al.
ANTIVIRAL RESEARCH (2017)
Biomimetic and bioinspired nanoparticles for targeted drug delivery
Mariacristina Gagliardi
THERAPEUTIC DELIVERY (2017)
Current applications of nanoparticles in infectious diseases
Hinojal Zazo et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues
Edita M. Klimyte et al.
JOURNAL OF VIROLOGY (2016)
Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection
Xiao Xi Yang et al.
NANOSCALE (2016)
Curcumin inhibits HIV-1 by promoting Tat protein degradation
Amjad Ali et al.
SCIENTIFIC REPORTS (2016)
Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs
Fabrizio Chiodo et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2014)
Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF
Laura L. Hurley et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Dissecting the Pharmacophore of Curcumin. Which Structural Element Is Critical for Which Action?
Alberto Minassi et al.
JOURNAL OF NATURAL PRODUCTS (2013)
Curcumin nanoformulations: a future nanomedicine for cancer
Murali M. Yallapu et al.
DRUG DISCOVERY TODAY (2012)
Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy
Dale L. Barnard et al.
FUTURE VIROLOGY (2011)
Celastrol Inhibits Tat-Mediated Human Immunodeficiency Virus (HIV) Transcription and Replication
Vivek Narayan et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Inhibition of HSV-1 Attachment, Entry, and Cell-to-Cell Spread by Functionalized Multivalent Gold Nanoparticles
Dana Baram-Pinto et al.
SMALL (2010)
Curcumin as Curecumin:: From kitchen to clinic
Ajay Goel et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus
Chih-Chun Wen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Angiotensin-converting enzyme 2 in lung diseases
Keiji Kuba et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs
XW Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Share Paper
